Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Diffuse Large B Cell Lymphoma
Clinical trial NCT02728882 · UNKNOWN
Trial details
- NCT number
- NCT02728882
- Sponsor
- Sinobioway Cell Therapy Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-02
- Primary completion
- 2019-07-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.